Resveratrol, or its glycoside form piceid, is a dietary antioxidant polyphenolic compound, found in grapes and red wine that has been shown to have protective effects against cardiovascular disease. However, very low water solubility of the compound may limit its application in the food and pharmaceutical industries. The amylosucrase (AMAS) of Alteromonas macleodii Deep ecotype was expressed in Escherichia coli and showed high glycosyltransferase activity to produce the glucosyl piceid when piceid was used as an acceptor. The conversion yield of piceid glucoside was 35.2%. Biotransformation using culture of the E. coli harboring the amas gene increased the yield up to 70.8%. The transfer product was purified by reverse phase chromatography and recycling preparative HPLC, and the molecular structure of the piceid glucoside was determined using NMR spectroscopy. The piceid glucoside was identified as glucosyl-α-(1→4)-piceid. The solubility of glucosyl piceid was 5.26 and 1.14 times higher than those of resveratrol and piceid, respectively. It is anticipated that dietary intake of this compound is more effective by enhancing the bioavailability of resveratrol in the human body because of its hydrophilic properties in the intestinal fluid.
Keywords: Amylosucrase, Alteromonas macleodii Deep ecotype, biotransformation, piceid, resveratrol, transglycosylation trans-Resveratrol (trans-3,5,4-trihydroxystilbene) is a polyphenolic phytoalexin with strong antioxidative activity, which is isolated from a variety of plant species and synthesized. Resveratrol has been reported to have potential chemopreventive activity against cardiovascular disease and a variety of cancers in model systems [2, 18, 19] .
However, resveratrol mostly exists as its glycoside form, trans-piceid (5,4-dihydroxystilbene-3-O-β-D-glucopyranoside), in wine [15] . After oral administration in humans, the trans-piceid is hydrolyzed by a β-glucosidase in the small intestine, and the converted resveratrol is efficiently absorbed across intestinal Caco-2 cells and metabolized to glucuronides or sulfated derivatives [6, 18] .
Even though trans-resveratrol and trans-piceid have therapeutic benefits, their water-insolubility limits their pharmacological exploitation in industry. Much effort has been made to increase the solubility of natural polyphenols. One method is to use cyclodextrin, which is widely employed as an excipient to increase the solubility and stability of drugs and chelate-isoflavone. Gu [4] reported that a cyclodextrin-isoflavone complex increased solubility by 2-6 times. However, the use of this complex is problematic because of the cloudiness of its solution. The other way to enhance the water solubility is to add a sugar moiety to the compound by enzymatic transglycosylation or biotransformation using cultured cells. Although chemical synthesis of glycosides is reasonable, it generates a lot of waste. The method also includes several protection and deprotection steps of the substrates and products, unlike enzymatic synthesis. Higher selectivity and specificity of enzymatic synthesis can overcome the limitation of chemical synthesis and provide an important green tool to obtain glycosylated products without toxic solutions and heavy metals [16] . Phenolic compounds such as arbutin, naringin, neohesperidin, and salicin have been glycosylated using bacterial glycosidases and/or glycosyltransferases [3, 8, 9, 12] . α-Oligoglucosylation of a sugar moiety by enzymatic synthesis enhances the bioavailability of quercetin glucosides in humans [13] . Enzymatic and microbial transformations of puerarin have also been examined, which rendered higher stereoselectivity and produced some specific compounds that suffered difficulty acquiring through chemical approaches [11, 20] . Puerarin glucosides synthesized by bioconversion using Microbacterium oxydans CGMCC 1788 exhibited superior water solubility and improved pharmacokinetic properties, while maintaining original bioactivity [7] .
Alteromonas macleodii Deep ecotype is a Gramnegative, mesophilic, heterotrophic bacterium. It belongs to the genus of Proteobacteria and is an obligate marine bacterium isolated at a depth of 3,500 m in the Urania Basin [5] . The genome of A. macleodii has been sequenced and made available at the National Center for Biotechnology Information (NCBI). A putative amylosucrase (ASase) tagged MADE_00676 is located in the genome of the A. macleodii Deep ecotype. To purify the putative ASase and obtain the recombinant E. coli cells bearing the gene, the putative MADE_00676 was isolated from A. macleodii Deep ecotype. Based on the fact that ASase forms an α-1,4-linked glucan polysaccharide, we hypothesized that the putative ASase could synthesize soluble piceid glucoside via tranglycosylation [8] . In this study, we expressed the gene for ASase from the A. macleodii Deep ecotype by transforming E. coli BL21(DE3) and used the glycosyl transfer activity of ASase to synthesize a piceid glucoside. The transglycosylation reaction was successfully conducted with piceid as the acceptor and sucrose as the donor using the purified AMAS and the recombinant E. coli cell culture. The molecular structure of the transglycosylation product, piceid glucoside, was determined and its water solubility was examined. 
MATERIALS AND METHODS

Chemicals and Reagents
Construction of amas Gene Expression Vector
In order to detect a potential amylosucrase gene (amas), Alteromonas macleodii Deep ecotype ORF (MADE_00676)-encoded ASase was compared with other genes through a BLAST search. PCR amplification of amas was performed with A. macleodii Deep ecotype genomic DNA as a template, using Takara prime STAR polymerase and the amas-specific primers AmaASU-Nde1-f (5'-GTTACATATGAGCTATGCTGCTG-3') and AmaASU-Xho1-R (5'-AGACTCGAGGACAGGCTGCAAC-3'), which respectively contained NdeI and XhoI restriction enzyme sites (underlined). The amasspecific internal primers were designed based on the A. macleodii Deep ecotype putative ASase nucleotide sequence. The PCR conditions were as follows: 30 cycles at 98 o C for 10 s (denaturation), 55 o C for 15 s (annealing), and 72 o C for 2 min (extension). The 1,947 bp product was purified with a PCR purification kit and then digested with NdeI and XhoI. This was then ligated into the expression vector pET29b(+) (Novagen, Billerica MA, USA) and digested with the corresponding restriction enzymes to generate pET29b-amas. The nucleotide sequence of the PCR-generated gene was determined using a BigDye Terminator Cycle Sequencing Kit for ABI 3700 PRISM (Perkin-Elmer, Norwalk, CT, USA). The resulting recombinant plasmid pET29b-amas was transformed into E. coli strain BL21(DE3).
Expression and Purification of Recombinant AMAS
The recombinant E. coli BL21(DE3) harboring pET29b-amas was grown in Luria-Bertani (LB) medium containing kanamycin (30 µg/ml) overnight at 37 o C for small-scale culture. The culture was then transferred into fresh LB medium (1:100 dilution) at 37 o C, and the T7 promoter of the plasmid was induced with 0.1 mM isopropyl 1-thio-β-D-galactoside (IPTG) at an optical density (600 nm) of 0.5-0.6 for protein expression. After 3 h of IPTG induction, the cells were harvested by centrifugation at 8,000 ×g for 20 min at 4 o C and resuspended in 20 mM sodium phosphate buffer, pH 7.4. The harvested cells were disrupted by sonication on an ice bath. The crude cell extract was centrifuged at 12,000 ×g for 30 min at 4 o C to remove the cellular debris. The supernatant fraction was filtered using a 0.45 µm syringe filter (Sartorius, Goettingen, Germany), and the resulting supernatant was subjected to nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography (Qiagen, Hilden, Germany) equilibrated with 20 mM sodium phosphate (pH 7.4) including 0.5 M NaCl. After washing the column with a washing buffer (20 mM sodium phosphate, pH 7.4, 0.5 M NaCl, 40 mM imidazole), elution was carried out with an elution buffer (20 mM sodium phosphate, pH 7.4, 0.5 M NaCl, 100 mM imidazole). Vivaspin 6 (GE Healthcare/ Amersham, Freiburg, Germany) was used to remove excess imidazole and concentrate ASase in the protein solution. The purified enzyme was analyzed by gel electrophoresis in a 10% (w/v) sodium dodecyl sulfate-polyacrylamide (SDS-PA) gel [10] . This SDS-PA gel was visualized by staining with Coomassie Brilliant Blue R-350. The protein concentration was determined according to the Bradford method, using bovine serum albumin as the standard [1] .
AMAS Assay
The AMAS transglycosylation activity was determined by the dinitrosalicylic acid (DNS) method. The standard assay mixture (0.3 ml) was assayed at 45 o C for 10 min in a reaction mixture containing 50 mM buffer, 500 mM sucrose as a substrate, and 100 µg of AMAS. To identify the effect of pH on transglycosylation activity of AMAS, 50 mM buffer was used as follows; citrate-NaOH (pH 3.0-6.0), sodium phosphate (pH 6.0-7.0), Tris-HCl (pH 7.0-9.0), and glycine-NaOH (9.0-11.0). The influence of temperature on the activity of AMAS was examined in 50 mM Tris-HCl buffer (pH 8.0) in a range from 25 o C to 55 o C for 10 min. After enzyme reaction, the enzyme samples were mixed with 450 µl of DNS solution, and then the reaction mixtures were incubated at 80 o C for 15 min. Color development was measured at 575 nm and the specific activity was calculated using fructose as a standard. One unit was defined as the amount of enzyme that catalyzes the production of 1 µmol fructose per minute in the assay conditions. All enzyme assays were performed by preincubation for 10 min before adding enzyme.
Enzymatic Synthesis of Piceid Glucoside
The reaction mixture containing 5 mM piceid, 5 mM sucrose, and 50 mM Tris-HCl (pH 8.0) was preincubated at 30 o C for 10 min, and then AMAS (0.1 mg/ml) was added and incubation of the reaction mixture (10 ml) was continued for 12 h. The reaction was stopped by boiling for 10 min and placing the mixture tube in ice. The reaction mixture was centrifuged at 2,000 ×g for 10 min to get rid of the insoluble substance. The supernatant fraction was filtered using a 0.45 µm syringe filter.
Biotransformation of Piceid by
E. coli Cell Cultures E. coli BL21(DE3) containing pET29b-amas was cultured as described above in 10 ml of LB medium. After IPTG induction for 3 h, the E. coli cells were separated by centrifugation at 8,000 ×g for 10 min to remove the supernatant. The cells were washed twice with 20 mM sodium phosphate buffer (pH 7.4), and resuspended in the M9 medium (10 ml) containing kanamycin (30 µg/ml), 0.1 mM IPTG, 1 mM piceid, and 1 mM sucrose. Experiment with resting cells was carried out at 150 rpm at 30 o C in 250 ml Erlenmeyer flasks for 12 h. After incubation, the supernatant was obtained by centrifugation at 12,000 ×g for 10 min. The supernatant fraction was filtered using a 0.2 µm syringe filter (Pall, Port Washington, NY, USA) and analyzed by HPLC.
TLC and HPLC Analyses
The purified transfer products were analyzed using TLC as described previously [14] . HPLC analysis was performed on a Shiseido Nanospace SI-2 (Shiseido, Tokyo, Japan) HPLC system, which includes a UV detector (Shodex, Tokyo, Japan). Separation of piceid glucoside was carried out by reversed phase HPLC using a C 18 (4.6 × 250 mm) column (Shodex). Separation was performed at a flow rate of 1 ml/min with a mobile phase composed of buffer A (1% acetic acid in water) and buffer B (1% acetic acid in methanol). The run was set as 22% buffer B. The column temperature was 40 o C and the injection volume was 30 µl. The analysis was observed at 306 nm, where trans-resveratrol shows absorbance maxima.
Purification of Piceid Glucoside
The transfer products were separated by C 18 -T cartridge (100 mg/ml, Strata) and recycling preparative HPLC equipped with RI detector (JAI, Tokyo, Japan). A C 18 -T cartridge, previously activated using methanol and water, was used to absorb the piceid glucoside in the transglycosylation reaction mixture and to remove any sucrose and salts. The transglycosylation reaction mixture was filtered by a 0.45 µm syringe filter and subjected to C 18 -T cartridge. After washing twice, elution of transfer products was carried out with methanol. The main transfer products in methanol were purified using a combination W-252/W-251 polymeric gel filtration column (2 cm × 50 cm; JAI) in the recycling preparative HPLC. The mobile phase was 100% methanol at a flow rate of 3 ml/min. The fractions corresponding to the detected peaks were collected and freeze-dried. The purity of each sample was confirmed using TLC analysis.
α-Glucosidase Hydrolysis
The purified transfer product was dissolved in McIlvaine buffer (pH 5.0). Sulfolobus acidocaldarius α-glucosidase (MalA; 0.5 µg) was added to the solution containing 10 mM glucosyl piceid and incubated at 85 o C for 60 min. The reaction mixture was analyzed by TLC at 254 nm. 
Nuclear Magnetic Resonance Analysis The
Solubility Determination
Solubility of piceid or piceid glucoside was determined as described previously [14] .
RESULTS AND DISCUSSION
Purification of Recombinant AMAS The glycosyltransferase, designated AMAS, of the A. macleodii Deep ecotype was expressed in E. coli BL21(DE3) cells harboring pET29b-amas. AMAS was efficiently purified by Ni-NTA chromatography. Crude cell-free extracts gained from sonication were filtered and loaded onto a Ni-NTA affinity column. The size of the purified AMAS estimated by SDS-PAGE was approximately 74 kDa, which is close to the expected molecular mass deduced from the amino acid sequence of A. macleodii AMAS (Fig. 1 ). The yield of purified AMAS was about 14.5%.
Characterization of AMAS
ASase is highly useful for glycosylation of biomaterials owing to its ability to utilize sucrose, an inexpensive and abundant renewable substrate, as a glucose donor. The deepsea eco-environment is obviously different from other environments. Therefore, it is important to find out the optimal condition of AMAS for substrate hydrolysis and transglycosylation. To optimize transglycosylation conditions for synthesis of piceid glucoside, the pH range at which the recombinant AMAS was active was determined using sucrose as the substrate. The maximum activity was observed at pH 8.0 (Fig. 2A) . The optimal temperature of AMAS was 37 o C, and the activity was sharply decreased above 42 o C (Fig. 2B) . Based on these results, the transglycosylation reaction was carried out at 37 o C and pH 8.0. ASase is known for having unique substrate specificity, strictly to transfer glucosyl units and form amylose or other glucosyl transfer products. It has been reported that ASase (DGAS) from Deinococcus geothermalis transferred a glucose moiety of sucrose to the C-4 position in the glucose residue of arbutin and salicin [8, 17] . AMAS also produced amylose when sucrose was used as a substrate. These results indicate that AMAS from A. macleodii Deep ecotype is indeed an ASase that transfers the glucosyl unit exclusively, even though DGAS has more outstanding transglycosylation activity compared with AMAS.
Glucosylation of Piceid by AMAS
AMAS was reacted with piceid in the presence of sucrose as a donor molecule. On the TLC plate, one major transglycosylated spot, possibly newly produced piceid glucoside, was observed after the AMAS reaction (Fig. 3) . This spot was detected under UV light (data not shown), implying that it originated from piceid, since piceid was the only chromophore in the reaction. TLC analysis of the AMAS reaction with sucrose and piceid suggested that the glucosyl-transfer activity of AMAS was successfully used to produce the piceid glucoside. Other polyphenols such as aesculin and arbutin were also good acceptors for transglycosylation by AMAS (data not shown). When the DGAS of Deinococcus geothermalis was used to transglycosylate arbutin, the major arbutin glycoside transfer product was determined to be glucosyl salicin [8] . Likewise, the newly produced piceid glucoside product observed in the AMAS transglycosylation reaction was believed to be a glucosyl unit attached to piceid. The conversion yield of piceid glucoside was 35.2% through enzymatic synthesis by the purified AMAS. Bioconversion using recombinant E. coli cells harboring the amas gene showed approximately 71% yield of the glucosyl piceid, estimated by HPLC (Fig. 4) . The yield by biotransformation was much higher than that of enzymatic synthesis. If the reaction condition of biotransformation is more investigated and optimized, we can expect that the functional glycosides will be easily produced and obtained for large-scale production.
Structural Analysis of Glucosyl Piceid
The sugars included in the transglycosylation reaction mixture were firstly discarded by a reverse phase C 18 -T column, and then the mixture of resveratrol glucosides in methanol was separated by using recycling preparative HPLC combined with a W-251 and W-252 polymeric gel filtration column. The presence of the piceid and piceid glucoside was detected by a refractive index detector (Fig. 5 ). TLC analysis of each peak fraction confirmed that each fraction was made up of a single compound. The molecular structure of the newly synthesized piceid glucoside was predicted based on the transglycosylation mechanism of the AMAS. The transfer product was isolated and the molecular structure was confirmed by enzymatic digestion and 1 H and 13 C NMR analyses. α-Glucosidase releases α-glucose residues from the nonreducing end of a polysaccharide chain by the hydrolysis of the α-1,4-glucosidic linkage [14] . When the major transfer product was treated with α-glucosidase for 1 h, the compound was eventually released into piceid and glucose (data not shown). This result indicated that the glucose unit was attached to the glucose moiety of piceid and that the new linkage formed between the glucose and glucose of piceid was an α-1,4-glucosidic bond, because α-glucosidase normally hydrolyzed α-1,4-glucosidic linkages. Nevertheless, the accurate molecular structure of the glucosyl piceid was identified by using NMR analysis. The 1 H and
13
C NMR spectra of the transfer product were compared with that of piceid. The anomer proton signals were detected and the bonds between the 2 glucose molecules were determined to be α-glucosidic linkages according to the coupling constant (J = 4.0 Hz) in the 1 H NMR spectrum. The coupling constant value (J = 8.0 Hz) of one anomeric proton signal indicates the β-linkage between the glucose moiety and aglycone resveratrol in piceid. The assignment of the carbon signal showed that the transferred glucosyl group was connected to C-4'' of piceid (Fig. 6) . Based on the result, the transfer product of piceid by AMAS was defined to be α-D-glucosyl-(1→4)-piceid. These results mean that the α-1,4-glycosidic linkage formed in the transglycosylation reaction is easily hydrolyzed by various glycosyl hydrolases, such as α-glucosidase, implying that the human body metabolizes piceid glucoside in the same way as piceid or resveratrol itself. This suggests that the bioavailability of piceid glucoside might not change greatly.
Water Solubility of Piceid and Piceid Glucoside
The solubility of glucosyl piceid in water was evaluated by comparing the retention time of glucosyl piceid with that of piceid by HPLC analysis combined with C 18 column. We could imply that glucosyl piceid (8.59 min) is more soluble than piceid (9.30 min), which is known as a natural resveratrol glucoside owing to its short retention time compared with piceid (Fig. 4) . This implies that the attachment of a The inset shows the purified transfer product. R, piceid and sucrose reaction products; 1, the piceid transfer product; 2, unreacted piceid. glucosyl residue to piceid by AMAS enhanced the water solubility of the original compound. Excess piceid or glucosyl piceid was suspended and sonicated in water to investigate its water solubility. We found that the solubility of piceid and glucosyl piceid was identified as 0.069 g/l and 0.079 g/l, respectively. The solubility of glucosyl piceid was 1.14 times higher than that of natural piceid. Compared with the resveratrol, which has no glucose moiety, the solubility was increased by 5.26-fold. After oral administration, unmetabolized resveratrol remains at low a level in human plasma because of poor absorption and ready conversion to its metabolites (glucuronidated or sulfated forms), even though resveratrol and piceid have beneficial biological activities in humans [19] . To apply the resveratrol as one of the effective medicinal supplements, it is necessary to increase the amount of unmetabolized compound at the target site at which resveratrol exerts biological activity. In our study, the enzymatic transglycosylation or biotransformation by AMAS or AMAS-expressed cells succeeded to produce glucosyl piceid, but was not effective to enhance solubility dramatically. We are trying to use maltosyltransferase to increase the solubility of piceid [14] . In preliminary result, it seems to increase the solubility of resveratrol more efficiently.
To summarize, the enzymatic transglycosylation using AMAS and/or biotransformation using AMAS-expressed E. coli cells are powerful techniques to produce watersoluble natural compound derivatives that have industrial potential in the commercial market. Various polyphenolic compounds such as aesculin or genistin are being examined to develop effective drugs having hydrophilic property. In the future, we anticipate that the glycosylation of biologically active compounds will be an alternative to pre-existing lipophilic drugs to increase bioavailability and delay the rapid conversion of those compounds.
